Xi Qin

Xi Qin, MBA has over 20 years of leadership experience in finance, M&A, international business, operations improvement, people processes and HR, corporate development and general management.

Prior to joining NeuExcell, Mr. Qin was Chief Operating Officer at GENEWIZ, a global leader in genomics services. During his 10-year tenure at GENEWIZ, Xi's role expanded from Corporate Controller to Chief Financial Officer to General Manager, while he led the business growth from $9M to $120M, expanded the operations from U.S. to China/Europe/Japan with >1,000 team members, and managed its strategic sale to Brooks Automation for $450M in 2018. Before GENEWIZ, Xi had 10 years of progressive experiences in corporate finance and operations at Northwest Airlines and Eli Lilly.

Xi has an MBA in Healthcare Management from Duke University, an MA in Immunology from Harvard University, and a BS in Biochemistry from Peking University.